Quem somos nós

J. Taylor Hays, M.D., Chair

J Taylor Hays, M.D.

Director, Mayo Clinic Nicotine Dependence Center

Expertise: Tobacco dependence and treatment, including pharmacological and behavioral therapies and research on the genetic basis for tobacco use and dependence.

Career highlights:

  • Professor of medicine, College of Medicine, Mayo Clinic
  • Consultant, Division of General Internal Medicine, Mayo Clinic in Rochester
  • Master’s faculty privileges in clinical and translational science, Mayo Graduate School, College of Medicine, Mayo Clinic


Richard D. Hurt, M.D.

Director Emeritus and Founder, Mayo Clinic Nicotine Dependence CenterRichard D. Hurt, M.D.

Expertise: Internationally recognized expert on evidence-based tobacco dependence treatment, research and education.

Career highlights:

  • Professor of medicine, College of Medicine, Mayo Clinic
  • Consultant to the Hong Kong Department of Health and other ministries of health
  • First witness in the historic Minnesota tobacco trial
  • Author or co-author of more than 200 scientific publications on nicotine dependence


Karla Wysocki, MA

Senior Director, Hospital Systems, American Cancer SocietyKarla Wysocki, MA

Expertise: Experienced non-profit manager, particularly with health system collaborations and strategic account management.

Career highlights:

  • Director, American Cancer Society-Midwest Division, Patient Navigation and Health Systems (Hospitals) Account Management Programs
  • Led state tobacco-free hospital collaboration efforts (Iowa) and experienced in community mobilization around smoke-free efforts


Katherine E. Kemper, MBA

Executive Director, Global Bridges

Expertise: Experienced global manager/marketer in the for-profit and not-for profit sectors.

Career highlights:

  • Director, Latin America Programs, Campaign for Tobacco-Free Kids
  • Vice president, Global Smoking Control, GlaxoSmithKline Consumer Healthcare
  • Introduced products and programs to help tobacco users in more than 18 countries escape their dependence


Thomas Glynn, PhD

Director, Cancer Science and Trends andThomas Glynn, PhD
Director, International Cancer Control, American Cancer Society, RET.

(The American Cancer Society is a founding partner of Global Bridges.)